After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company ...

US clinical stage biotech Alector saw its shares tumble 35% to $2.57 by close of trading yesterday, as it announced ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

The Down syndrome treatment market in the USA is valued at nearly $250 million, with companies like Aelis Farma, AC Immune, ...

Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed ADC for ...

The strain of opioid use disorder (OUD), a chronic neurological disorder characterized by the compulsive, repeated use of ...

AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now ...

Japanese drugmaker Otsuka has announced the submission of a New Drug Application (NDA) to the Japanese Ministry of Health, ...

The Biden administration has proposed a new rule that could significantly expand Medicare and Medicaid coverage for obesity ...

PTC Therapeutics' Phase II trial for utreloxastat in ALS failed to meet its primary endpoint, showing no significant ...

Berlin, Germany-based Eckert & Ziegler Radiopharma has received approval of its proprietary non-carrier added Lutetium-177 ...

Samsung Bioepis has appointed Kyung-Ah Kim as president and CEO, succeeding Christopher Hansung Ko. The leadership change ...